Matches in SemOpenAlex for { <https://semopenalex.org/work/W2988361260> ?p ?o ?g. }
- W2988361260 endingPage "430" @default.
- W2988361260 startingPage "422" @default.
- W2988361260 abstract "ABSTRACT Objective To describe our clinical experience across the entire range of fetal‐fraction (FF) measurements of a non‐invasive prenatal screen (NIPS) that uses whole‐ genome sequencing (WGS). Methods We analyzed retrospectively results from 58 105 singleton pregnancies that underwent NIPS on a customized WGS platform during an 8‐month period and assessed clinical test performance for trisomy 21, trisomy 18 and trisomy 13. Pregnancy outcomes were sought for all screen‐positive patients and for 18% of screen‐negative patients. As differences in outcome‐collection response rates could artificially impact test‐performance calculations, we computed inferred sensitivity, specificity, positive predictive values (PPV) and negative predictive values adjusted for ascertainment bias. Results The screening test yielded a result for 99.9% ( n = 58 048) of patients, meaning that approximately 1 in 1000 patients received a test failure (i.e. test failure rate = 0.1%). Of pregnancies with a test result, 572 (1%) screened positive for one of the common aneuploidies (362 for trisomy 21, 142 for trisomy 18 and 68 for trisomy 13). Informative outcomes were received for 237 (41.4%) patients with a screen‐positive result and 3258 (5.7%) of those with a screen‐negative result. In the full cohort, inferred sensitivities for trisomy 21, trisomy 18 and trisomy 13 were 99.7%, 96.8% and 94.3%, respectively, and PPVs were 93.1%, 85.2% and 48.4%, respectively. If a FF threshold of 4% had been employed to guard against false negatives, calculated sensitivities for the three aneuploidies would not have changed significantly, yet, importantly, the overall test‐failure rate would have increased to 6.6% ( n = 3829), impacting 1 in 15 women. Conclusions Our clinical experience demonstrates that a customized WGS‐based NIPS without a FF threshold achieves high accuracy while maintaining a low test‐failure rate of 0.1%. As such, alternative strategies to ensure high accuracy of detection of common aneuploidies in samples with low FF (such as redraw after test failure, redrawing at a later gestational age, risk scoring based on FF) are not necessary for this screening approach. © 2019 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology." @default.
- W2988361260 created "2019-11-22" @default.
- W2988361260 creator A5014702331 @default.
- W2988361260 creator A5023669540 @default.
- W2988361260 creator A5044746926 @default.
- W2988361260 creator A5073544172 @default.
- W2988361260 creator A5079996891 @default.
- W2988361260 creator A5085158136 @default.
- W2988361260 creator A5087674563 @default.
- W2988361260 creator A5091909433 @default.
- W2988361260 date "2020-09-01" @default.
- W2988361260 modified "2023-10-16" @default.
- W2988361260 title "Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate" @default.
- W2988361260 cites W1530237392 @default.
- W2988361260 cites W1583962399 @default.
- W2988361260 cites W1757144522 @default.
- W2988361260 cites W1779744604 @default.
- W2988361260 cites W1941739197 @default.
- W2988361260 cites W2023879574 @default.
- W2988361260 cites W2056785446 @default.
- W2988361260 cites W2069401773 @default.
- W2988361260 cites W2083518637 @default.
- W2988361260 cites W2098964174 @default.
- W2988361260 cites W2119528684 @default.
- W2988361260 cites W2123370218 @default.
- W2988361260 cites W2133949629 @default.
- W2988361260 cites W2144067971 @default.
- W2988361260 cites W2155553535 @default.
- W2988361260 cites W2160764289 @default.
- W2988361260 cites W2202940916 @default.
- W2988361260 cites W2237006946 @default.
- W2988361260 cites W2329465801 @default.
- W2988361260 cites W2485046853 @default.
- W2988361260 cites W2505802187 @default.
- W2988361260 cites W2598689715 @default.
- W2988361260 cites W2607030666 @default.
- W2988361260 cites W2798070396 @default.
- W2988361260 cites W2809446750 @default.
- W2988361260 cites W2887336438 @default.
- W2988361260 cites W4251245750 @default.
- W2988361260 doi "https://doi.org/10.1002/uog.21904" @default.
- W2988361260 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7496885" @default.
- W2988361260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31671482" @default.
- W2988361260 hasPublicationYear "2020" @default.
- W2988361260 type Work @default.
- W2988361260 sameAs 2988361260 @default.
- W2988361260 citedByCount "19" @default.
- W2988361260 countsByYear W29883612602020 @default.
- W2988361260 countsByYear W29883612602021 @default.
- W2988361260 countsByYear W29883612602022 @default.
- W2988361260 countsByYear W29883612602023 @default.
- W2988361260 crossrefType "journal-article" @default.
- W2988361260 hasAuthorship W2988361260A5014702331 @default.
- W2988361260 hasAuthorship W2988361260A5023669540 @default.
- W2988361260 hasAuthorship W2988361260A5044746926 @default.
- W2988361260 hasAuthorship W2988361260A5073544172 @default.
- W2988361260 hasAuthorship W2988361260A5079996891 @default.
- W2988361260 hasAuthorship W2988361260A5085158136 @default.
- W2988361260 hasAuthorship W2988361260A5087674563 @default.
- W2988361260 hasAuthorship W2988361260A5091909433 @default.
- W2988361260 hasBestOaLocation W29883612601 @default.
- W2988361260 hasConcept C104317684 @default.
- W2988361260 hasConcept C126322002 @default.
- W2988361260 hasConcept C131872663 @default.
- W2988361260 hasConcept C172680121 @default.
- W2988361260 hasConcept C2776229224 @default.
- W2988361260 hasConcept C2778258057 @default.
- W2988361260 hasConcept C2779234561 @default.
- W2988361260 hasConcept C2779672484 @default.
- W2988361260 hasConcept C29456083 @default.
- W2988361260 hasConcept C30481170 @default.
- W2988361260 hasConcept C54355233 @default.
- W2988361260 hasConcept C71924100 @default.
- W2988361260 hasConcept C72563966 @default.
- W2988361260 hasConcept C86803240 @default.
- W2988361260 hasConceptScore W2988361260C104317684 @default.
- W2988361260 hasConceptScore W2988361260C126322002 @default.
- W2988361260 hasConceptScore W2988361260C131872663 @default.
- W2988361260 hasConceptScore W2988361260C172680121 @default.
- W2988361260 hasConceptScore W2988361260C2776229224 @default.
- W2988361260 hasConceptScore W2988361260C2778258057 @default.
- W2988361260 hasConceptScore W2988361260C2779234561 @default.
- W2988361260 hasConceptScore W2988361260C2779672484 @default.
- W2988361260 hasConceptScore W2988361260C29456083 @default.
- W2988361260 hasConceptScore W2988361260C30481170 @default.
- W2988361260 hasConceptScore W2988361260C54355233 @default.
- W2988361260 hasConceptScore W2988361260C71924100 @default.
- W2988361260 hasConceptScore W2988361260C72563966 @default.
- W2988361260 hasConceptScore W2988361260C86803240 @default.
- W2988361260 hasIssue "3" @default.
- W2988361260 hasLocation W29883612601 @default.
- W2988361260 hasLocation W29883612602 @default.
- W2988361260 hasOpenAccess W2988361260 @default.
- W2988361260 hasPrimaryLocation W29883612601 @default.
- W2988361260 hasRelatedWork W1985000757 @default.
- W2988361260 hasRelatedWork W1987080281 @default.
- W2988361260 hasRelatedWork W2031220510 @default.
- W2988361260 hasRelatedWork W2071475960 @default.